Impaired cardiac
fatty acid uptake, assessed by the radiolabelled
fatty acid analogue beta-methyl-p-iodophenyl
pentadecanoic acid (I-123-BMIPP), is observed in the myocardium following acute ischaemic events, but the long-term prognostic implication has not been established. This study aimed to determine the prognostic value of cardiac
BMIPP uptake in patients with acute
myocardial infarction. Following the assessment of
thallium-201 and I-123-BMIPP uptake, 101 post-
infarct patients were prospectively followed up with primary end points of
cardiac death,
heart failure and non-fatal
infarction. During a mean follow-up of 28 months, three cardiac deaths, three non-fatal
infarctions, 23 revascularizations and four recurrences of
angina pectoris were observed. Multivariate analysis identified reduced uptake of
BMIPP and perfusion, no beta-blocking treatment and greater
thallium-
BMIPP mismatch (i.e. larger
BMIPP defect than
thallium defect) as significant predictors for overall
cardiac events. Prior
myocardial infarction, reduced left ventricular ejection fraction and greater
thallium-
BMIPP mismatch were selected as independent predictors of harder
cardiac events. Female patients, those with greater
BMIPP defect or greater
thallium-
BMIPP mismatch showed worse clinical outcomes. The inclusion of
BMIPP data improved the prognostic values of conventional significant predictors. In conclusion, impaired myocardial I-123-BMIPP uptake and perfusion-
BMIPP mismatch are related to a high probability of fatal and non-fatal
cardiac events, suggesting the aetiological relevance and prognostic value of impaired cardiac
fatty acid metabolism in viable, but jeopardized, myocardium following acute
myocardial infarction.